BMS1 and cervical carcinoma: The increased sample size enabled identification of SMGs previously unreported in cervical carcinoma including NBPF10 (8%), RANBP2 (6%), MSN (6%), KRT8 (6%), POTEC (6%), ZC3H11A (4%), BMS1 (4%), GPX1 (3%), OTOP1 (3%), DNAH12 (2%), COIL (2%), TBC1D26 (2%), SPRED3 (2%), FAM115A (2%), and ARIH1 (1%) (Table 1).